WHO ICTRP trial
AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III STUDY OF SECOND-LINE…
EUCTR2007-002886-11-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2007-002886-11-IT |
|---|---|
| Public title | AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III STUDY OF SECOND-LINE CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS WHO HAVE RECEIVED FIRST-LINE CHEMOTHERAPY PLUS BEVACIZUMAB - BEBYP |
| Scientific title | AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III STUDY OF SECOND-LINE CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS WHO HAVE RECEIVED FIRST-LINE CHEMOTHERAPY PLUS BEVACIZUMAB - BEBYP |
| Primary sponsor | G.O.N.O. - GRUPPO ONCOLOGICO NORD OVEST |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | METASTATIC COLORECTAL CANCER PATIENTS MedDRA version: 9.1 Level: LLT Classification code 10052358 Term: Colorectal cancer metastatic |
| Interventions | Trade Name: AVASTIN Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: Bevacizumab Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- Product Name: Oxaliplatin Pharmaceutical… |
| Registration date | Jun 2, 2008 |
| Secondary IDs | BEBYP |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: